Key points: Cardiovascular toxicities are higher in older patients, but nonrelapse mortality at 100 days and 1 year is comparable to younger patients. Although mitigation of BEAM toxicities is needed, withholding this potentially curative therapy, based on age only, is not recommended.
Home / Resource Library / Toxicities of high-dose chemotherapy and autologous hematopoietic cell transplantation in older patients with lymphoma